Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 902219 Boston, MA

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,939,250
+$1,997,885 QoQ
Shares Held
293,925
+197.2% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 316 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 0% Shared 98% None 2%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. BCRX ranks #17 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCRX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,939,250 293,925
2026-03-31 $941,365 98,883
2025-12-31 $674,855 86,520
2025-09-30 $709,891 93,530
2025-06-30 $777,529 86,778
2025-03-31 $685,109 91,348
2024-12-31 $669,707 89,057
2024-09-30 $819,430 107,820